Problems associated with the clinical use of radiopharmaceuticals can usually be classified into one of four categories: unusual imaging results, adverse reactions, unique difficulties encountered in special patient populations, and quality assurance failures. Each of these problem areas is briefly described and a guide for troubleshooting such problems is presented.